4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly
- PMID: 24526060
- DOI: 10.1161/STROKEAHA.113.002700
4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly
Keywords: controlled clinical trials, randomized; stroke; thrombolytic therapy.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
